Dundee Corp DDEJF

Primary Symbol: T.DC.A

Healthcare Metals & Mining Technology Gold Industrial Metals & Minerals Silver

Dundee Corporation is a Canada-based holding company. Through its operating segments, the Company is a mining- focused investor primarily engaged in acquiring mineral resource assets. Its segments include mining investments, mining services, and corporate and others. Its asset base includes investments in precious and base metals projects across four continents. Its subsidiaries include Dundee Sustainable Technologies Inc. (Dundee Technologies), Dundee Resources Limited, and Goodman & Company, Investment Counsel Inc. The Dundee Sustainable Technologies Inc., a 78%-owned subsidiary developing patented sustainable precious and base metals extraction processes. Through the development of its patented processes, the GlassLock Process and the CLEVR Process, Dundee Technologies extracts precious and base metals from ores and concentrates, while stabilizing contaminants such as arsenic.

TSX:DC.A - Post by User

Dundee Corp > TauRx update from Genting site

<< Previous

Bullboard Posts

Next >>

Comment by pierrelebelon Nov 18, 2024 4:43pm

82 Views

Post# 36318709

RE:RE:TauRx update from Genting site

Hi Catscratch.

Sorry, wrong choice of words, my bad, I am referring to the Genting discussion board, through I3 investor. Genting is the largest shareholder of TauRx (about 20%+)

These posters - at times - seem well informed yet there is a lot of in-fighting and nonsense.

For example today:

Dont bother with TauRx - got hundreds other alzheimer med under Phase 2/3 clinical trials
Current share price values TauRx at 0 - so TauRx failure only minimal affect share price.

Taurx is almost 99.9% chance of getting approval. Both the theory and execution looks very promising. Don't think it can go wrong. I would bet good money on it given that it is already passed all hurdles.

I strong believe Genting Taurx 4mg pill already in production and being used by patients. The medical community is not going to wait 5 months for the approval since July 30 application for approval. The approval is just a step to make it official that's all.

HMTM entered Phase 3 clinical trials in 2021. The first 12-month double-blind phase of the trial has been completed, and the second 12-month open-label phase is currently ongoing.

I strong believe Genting Taurx 4mg pill already in production and being used by patients. The medical community is not going to wait 5 months for the approval since July 30 application for approval. The approval is just a step to make it official that's all.

Taurx lucidity trial has been too conservative on drug dosage. Until now we are still unable to solve placebo issues. We all hope regulators are able to see beyond placebo issues n grant us approvals. There are always planted road blocks by competitors at regulatory levels.

------------------------------------------------------

The "placibo issue" is real in my opinion and may prevent approval at the FDA.

Click HERE for the LINK.

<< Previous

Bullboard Posts

Next >>

Sirios Resource discovers visible gold in Quebec